Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129655) titled 'Development of a Serological Monitoring Model for Liver Cancer Metastasis and an Interactive Application' on Aug. 7.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Jiangjin Central Hospital of Chongqing

Condition: liver cancer

Intervention: HCC Cohort(Metastatic Subgroup vs Non?Metastatic Subgroup):None Normal:None Other Solid Tumor Group (Lung Cancer):None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-21

Target Sample Size: HCC Cohort(Metastatic Subgroup vs Non?Metastatic Subgroup):200;Normal:100;Other Solid Tumor Group (Lung Cancer):...